ACM
ROIV icon

ADAR1 Capital Management’s Roivant Sciences ROIV Stock Holding History

ADAR1 Capital Management’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$112M Sell
3,157,008
-128,898
-4% -$3.81M 5.11% 3
2026
Q1 		$91M Sell
3,285,906
-143,056
-4% -$3.67M 5.36% 3
2025
Q4 		$74.4M Buy
3,428,962
+81,461
+2% +$1.61M 5.46% 3
2025
Q3 		$50.6M Buy
3,347,501
+1,406,704
+72% +$17.4M 4.76% 4
2025
Q2 		$21.9M Sell
1,940,797
-1,542,607
-44% -$16.7M 3.35% 7
2025
Q1 		$35.1M Sell
3,483,404
-25,290
-0.7% -$273K 6.52% 3
2024
Q4 		$41.5M Buy
3,508,694
+483,244
+16% +$5.71M 8.3% 1
2024
Q3 		$34.9M Sell
3,025,450
-1,124,559
-27% -$12.8M 5.68% 5
2024
Q2 		$43.9M Buy
4,150,009
+1,358,139
+49% +$14.9M 8.28% 3
2024
Q1 		$29.4M Buy
2,791,870
+1,535,279
+122% +$16.6M 6.68% 3
2023
Q4 		$14.1M Buy
+1,256,591
New +$12.2M 5.04% 4

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ADAR1 Capital Management's ROIV Position: Q2 2026 in Review

ADAR1 Capital Management reduced its Roivant Sciences (ROIV) stake by 3.9% in Q2 2026, selling an estimated $3.81M and leaving 3,157,008 shares worth $112M. The position accounts for 5.11% of the portfolio, ranked #3.

ADAR1 Capital Management first reported a position in ROIV in Q4 2023 and has held it in 11 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • ADAR1 Capital Management held 3,157,008 shares of Roivant Sciences worth $112M as of Q2 2026.
  • ADAR1 Capital Management sold 128,898 Roivant Sciences shares in Q2 2026, an estimated $3.81M.
  • Roivant Sciences made up 5.11% of ADAR1 Capital Management's portfolio in Q2 2026, its #3 holding.
  • ADAR1 Capital Management first reported a position in Roivant Sciences in Q4 2023 and has held it in 11 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on ADAR1 Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.